Evaluating 5 alpha reductase inhibitors for the treatment of male androgenic alopecia

被引:1
作者
Courtney, Ashling [1 ,2 ,5 ]
Triwongwarant, Daranporn [1 ,3 ]
Chim, Ivana [1 ]
Eisman, Samantha [1 ]
Sinclair, Rodney [1 ,4 ]
机构
[1] Sinclair Dermatol, Melbourne, Australia
[2] Monash Univ, Eastern Hlth Clin Sch, Clayton, Vic, Australia
[3] Mahidol Univ, Siriraj Hosp, Dept Dermatol, Bangkok, Thailand
[4] Univ Melbourne, Melbourne, Australia
[5] Sinclair Dermatol, 2 Wellington Parade East Melbourne, Melbourne, Vic, Australia
关键词
Finasteride; dutasteride; minoxidil; baldness; balding; DUTASTERIDE;
D O I
10.1080/14656566.2023.2280630
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:1919 / 1922
页数:4
相关论文
共 14 条
[1]  
Asfour L, 2000, Endotext
[2]  
Asfour L., 2023, J AM ACAD DERMATOL
[3]   Combination therapy with finasteride and low-dose dutasteride in the treatment of androgenetic alopecia [J].
Boyapati, Ann ;
Sinclair, Rodney .
AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2013, 54 (01) :49-51
[4]   Chronic telogen effluvium is due to a reduction in the variance of anagen duration [J].
Gilmore, Stephen ;
Sinclair, Rodney .
AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2010, 51 (03) :163-167
[5]   Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia [J].
Gupta, Aditya K. ;
Talukder, Mesbah ;
Williams, Greg .
JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (07) :2946-2962
[6]   MALE PSEUDOHERMAPHRODITISM SECONDARY TO 5ALPHA-REDUCTASE DEFICIENCY - MODEL FOR THE ROLE OF ANDROGENS IN BOTH THE DEVELOPMENT OF THE MALE PHENOTYPE AND THE EVOLUTION OF A MALE GENDER IDENTITY [J].
IMPERATOMCGINLEY, J ;
PETERSON, RE ;
GAUTIER, T ;
STURLA, E .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1979, 11 (01) :637-645
[7]   The Trichoscopy Derived Sinclair Scale: Enhancing visual assessment through quantitative trichoscopy [J].
Kasprzak, Michal ;
Sicinska, Justyna ;
Sinclair, Rodney .
AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2019, 60 (02) :134-136
[8]   Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride [J].
Kiguradze, Tina ;
Temps, William H. ;
Yarnold, Paul R. ;
Cashy, John ;
Brannigan, Robert E. ;
Nardone, Beatrice ;
Micali, Giuseppe ;
West, Dennis Paul ;
Belknap, Steven M. .
PEERJ, 2017, 5
[9]   Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial [J].
Piraccini, B. M. ;
Blume-Peytavi, U. ;
Scarci, F. ;
Jansat, J. M. ;
Falques, M. ;
Otero, R. ;
Tamarit, M. L. ;
Galvan, J. ;
Tebbs, V ;
Massana, E. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (02) :286-294
[10]  
Saceda-Corralo D, 2022, J DRUGS DERMATOL, V21, P742, DOI [10.36849/A0.6610, 10.36849/JDD.6610]